Rebrain services provide precise brain targeting for DBS neurosurgery, enhancing patient outcomes in Parkinson’s disease and Essential Tremor treatments

We are thrilled to share that FrenchWeb has featured RebrAIn for securing €3.7 million in seed funding to advance our AI-driven solutions for treating Parkinson’s Disease.

Led by Karista and supported by Nouvelle Aquitaine Co-Investissement, this funding will accelerate the international expansion of our innovative platform, OptimDBS, which aims to simplify and standardize Deep Brain Stimulation procedures. This significant investment underscores our commitment to enhancing patient outcomes and making neurosurgical treatments more accessible.

Read the full story here (in French).

An English translation by Google is available here.